Establishing national diagnostic reference levels in radiography, mammography, and dual-energy x-ray absorptiometry services in Ireland and comparing these with European diagnostic reference levels.

OBJECTIVES: The aim of this work was to establish national diagnostic reference levels (DRLs) in Ireland and compare these to existing European DRLs where available. This work surveyed all radiological facilities providing radiography, mammography, and dual-energy x-ray absorptiometry (DXA) services in Ireland. METHODS: A list of common procedures and clinical tasks was established. A national database of service providers was used to identify the appropriate medical radiological facilities providing these services. These facilities were issued with an online survey. National DRLs were set as the 75th percentile of the distribution of median values obtained. A national median dose was also established. The broad categorisation of equipment type was also considered. Where differences between DRLs established using different detector types were deemed statistically significant, equipment-specific national DRLs were established. RESULTS: National DRLs were established for 12 adult radiography projections. Equipment-specific (computed radiography and digital radiography) adult DRLs were established for four radiography projections. Paediatric DRLs were established for 11 radiography projections, including two based on clinical indications, for a range of paediatric weight categories. National DRLs were established for unilateral two-view mammography and breast tomosynthesis as well as for four DXA clinical indications and projections. All but one Irish DRL figure was found to be below or equal to European data. CONCLUSIONS: This work provided a unique opportunity to establish national DRLs based on census data for a range of procedures and clinical tasks across radiography, mammography and DXA and compare these with European levels. CLINICAL RELEVANCE STATEMENT: This work established national diagnostic reference levels (DRLs) based on census data for a range of procedures and clinical tasks across radiography, mammography and dual-energy x-ray absorptiometry. The establishment of national DRLs is an essential component in the optimisation of patient radiation dose. KEY POINTS: • Diagnostic reference levels are easily measured quantities intended for use as an aid to optimise patient dose and to identify when levels of patient dose are unusually high. • Data from all medical radiological facilities in Ireland was obtained to establish national diagnostic reference level (DRL) values and national median dose values in radiography, x-ray breast imaging and dual-energy x-ray absorptiometry (DXA) scanning and these were compared to existing European DRLs where available. • National DRL values were established for the first time in breast tomosynthesis, DXA scanning, and paediatric radiography.

Geometric accuracy of the MR imaging techniques in the presence of motion.

Magnetic Resonance Imaging (MRI) is increasingly being used for improving tumor delineation and tumor tracking in the presence of respiratory motion. The purpose of this work is to design and build an MR compatible motion platform and to use it for evaluating the geometric accuracy of MR imaging techniques during respiratory motion. The motion platform presented in this work is composed of a mobile base made up of a flat plate and four wheels. The mobile base is attached from one end and through a rigid rod to a synchrony motion table by Accuray® placed at the end of the MRI table and from the other end to an elastic rod. The geometric accuracy was measured by placing a control point-based phantom on top of the mobile base. In-house software module was used to automatically assess the geometric distortion. The blurring artifact was also assessed by measuring the Full Width Half Maximum (FWHM) of each control point. Our results were assessed for 50, 100, and 150 mm radial distances, with a mean geometric distortion during the superior-inferior motion of 0.27, 0.41, and 0.55 mm, respectively. Adding the anterior-posterior motion, the mean geometric distortions increased to 0.4, 0.6, and 0.8 mm. Blurring was observed during motion causing an increase in the FWHM of ≈30%. The platform presented in this work provides a valuable tool for the assessment of the geometric accuracy and blurring artifact for MR during motion. Although the main objective was to test the spatial accuracy of an MR system during motion, the modular aspect of the presented platform enables the use of any commercially available phantom for a full quality control of the MR system during motion.

Diagnostic Accuracy of 18F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.

The aim of this overview was to consolidate existing evidence syntheses and provide a comprehensive overview of the evidence for 18F-prostate specific membrane antigen (PSMA) PET/CT in the staging of high-risk prostate cancer and restaging after biochemical recurrence. An overview of reviews was performed and reported in line with the preferred reporting items for overview of reviews (PRIOR) statement and synthesis without meta-analysis (SWiM) reporting guidelines. A comprehensive database and grey literature search were conducted up to July 18, 2023. Systematic reviews were assessed using the risk of bias in systematic reviews (ROBIS) tool. The certainty of the evidence was assessed using grading of recommendations, assessment, development and evaluations (GRADE). 11 systematic reviews were identified; 10 were at high or unclear risk of bias. Evidence reported on a per-patient, per-lymph node, and per-lesion basis for sensitivity, specificity and overall accuracy was identified. There was a lack of data on dose, adverse events and evidence directly comparing 18F-PSMA PET/CT to other imaging modalities. Evidence with moderate to very low certainty indicated high sensitivity, specificity and accuracy of 18F-PSMA PET/CT in patients with high-risk prostate cancer and biochemical recurrence. There was considerably lower certainty evidence and greater variability in effect estimates for outcomes for the combined intermediate/high-risk cohort. While evidence gaps remain for some outcomes, and most systematic reviews were at high or unclear risk of bias, the current evidence base is broadly supportive of 18F-PSMA PET/CT imaging in the staging and restaging of patients with high-risk prostate cancer and biochemical recurrence.

Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews.

Background: Correct staging and risk stratification is essential in ensuring prostate cancer patients are offered the most appropriate treatment. Interest has been growing in the use of radiotracers targeting prostate specific membrane antigen (PSMA), including the use of 18F-PSMA PET-CT, as part of the primary staging or restaging of prostate cancer. Preliminary scoping identified a number of relevant systematic reviews and meta-analyses; however, individually, these each appear to look at only part of the picture. An overview of reviews aims to systematically identify, appraise and synthesise multiple systematic reviews, related to a relevant research question or questions. We present a protocol for an overview of reviews, which aims to collate existing evidence syntheses exploring the diagnostic accuracy of 18F-PSMA in staging and restaging of prostate cancer. It also aims to highlight evidence gaps in prostate cancer staging or restaging. Methods: This protocol is reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for systematic review protocols (PRISMA-P). The search strategy will be designed in consultation with a librarian. Searches will be performed in Medline (EBSCO), Embase (Ovid), Google Scholar and the Cochrane Database for Systematic Reviews, supplemented by a targeted grey literature search, forward citation searching and searching reference lists of included reviews. No language or date restrictions will be applied to the eligibility criteria or the search strategy. Title & abstract and full text screening will be performed independently by two reviewers. Data will be extracted by one reviewer and checked in full by a second reviewer. Quality appraisal will be performed using the Risk of Bias in Systematic Reviews (ROBIS) tool independently by two reviewers, and results will be narratively synthesised. Conclusions: This overview of reviews may be of interest to healthcare professionals, academics and health policy decision-makers. Registration: OSF (September 7, 2023).

Generation of synthetic CT using multi-scale and dual-contrast patches for brain MRI-only external beam radiotherapy.

PURPOSE: To create a synthetic CT (sCT) from conventional brain MRI using a patch-based method for MRI-only radiotherapy planning and verification. METHODS: Conventional T1 and T2-weighted MRI and CT datasets from 13 patients who underwent brain radiotherapy were included in a retrospective study whereas 6 patients were tested prospectively. A new contribution to the Non-local Means Patch-Based Method (NMPBM) framework was done with the use of novel multi-scale and dual-contrast patches. Furthermore, the training dataset was improved by pre-selecting the closest database patients to the target patient for computation time/accuracy balance. sCT and derived DRRs were assessed visually and quantitatively. VMAT planning was performed on CT and sCT for hypothetical PTVs in homogeneous and heterogeneous regions. Dosimetric analysis was done by comparing Dose Volume Histogram (DVH) parameters of PTVs and organs at risk (OARs). Positional accuracy of MRI-only image-guided radiation therapy based on CBCT or kV images was evaluated. RESULTS: The retrospective (respectively prospective) evaluation of the proposed Multi-scale and Dual-contrast Patch-Based Method (MDPBM) gave a mean absolute error MAE=99.69±11.07HU (98.95±8.35HU), and a Dice in bones DIbone=83±0.03 (0.82±0.03). Good agreement with conventional planning techniques was obtained; the highest percentage of DVH metric deviations was 0.43% (0.53%) for PTVs and 0.59% (0.75%) for OARs. The accuracy of sCT/CBCT or DRRsCT/kV images registration parameters was <2mm and <2°. Improvements with MDPBM, compared to NMPBM, were significant. CONCLUSION: We presented a novel method for sCT generation from T1 and T2-weighted MRI potentially suitable for MRI-only external beam radiotherapy in brain sites.

Characterization of 3D geometric distortion of magnetic resonance imaging scanners commissioned for radiation therapy planning.

OBJECTIVE: To develop a method for the assessment and characterization of 3D geometric distortion as part of routine quality assurance for MRI scanners commissioned for Radiation Therapy planning. MATERIALS AND METHODS: In this study, the in-plane and through-plane geometric distortions on a 1.5T GE MRI-SIM unit are characterized and the 2D and 3D correction algorithms provided by the vendor are evaluated. We used a phantom developed by GE Healthcare that covers a large field of view of 500mm, and consists of layers of foam embedded with a matrix of ellipsoidal markers. An in-house Java-based software module was developed to automatically assess the geometric distortion by calculating the center of each marker using the center of mass method, correcting of gross rotation errors and comparing the corrected positions with a CT gold standard data set. Spatial accuracy of typical pulse sequences used in RT planning was assessed (2D T1/T2 FSE, 3D CUBE, T1 SPGR) using the software. The accuracy of vendor specific geometric distortion correction (GDC) algorithms was quantified by measuring distortions before and after the application of the 2D and 3D correction algorithms. RESULTS: Our algorithm was able to accurately calculate geometric distortion with sub-pixel precision. For all typical MR sequences used in Radiotherapy, the vendor's GDC was able to substantially reduce the distortions. Our results showed also that the impact of the acquisition produced a maximum variation of 0.2mm over a radial distance of 200mm. It has been shown that while the 2D correction algorithm remarkably reduces the in-plane geometric distortion, 3D geometric distortion further reduced the geometric distortion by correcting both in-plane and through-plane distortions in all acquisitions. CONCLUSION: The presented methods represent a valuable tool for routine quality assurance of MR applications that require stringent spatial accuracy assessment such as radiotherapy. The phantom used in this study provides three dimensional arrays of control points. These tools and the detailed results can be also used for developing new geometric distortion correction algorithms or improving the existing ones.

Development and validation of a novel large field of view phantom and a software module for the quality assurance of geometric distortion in magnetic resonance imaging.

OBJECTIVE: To develop and validate a large field of view phantom and quality assurance software tool for the assessment and characterization of geometric distortion in MRI scanners commissioned for radiation therapy planning. MATERIALS AND METHODS: A purpose built phantom was developed consisting of 357 rods (6mm in diameter) of polymethyl-methacrylat separated by 20mm intervals, providing a three dimensional array of control points at known spatial locations covering a large field of view up to a diameter of 420mm. An in-house software module was developed to allow automatic geometric distortion assessment. This software module was validated against a virtual dataset of the phantom that reproduced the exact geometry of the physical phantom, but with known translational and rotational displacements and warping. For validation experiments, clinical MRI sequences were acquired with and without the application of a commercial 3D distortion correction algorithm (Gradwarp™). The software module was used to characterize and assess system-related geometric distortion in the sequences relative to a benchmark CT dataset, and the efficacy of the vendor geometric distortion correction algorithms (GDC) was also assessed. RESULTS: Results issued from the validation of the software against virtual images demonstrate the algorithm's ability to accurately calculate geometric distortion with sub-pixel precision by the extraction of rods and quantization of displacements. Geometric distortion was assessed for the typical sequences used in radiotherapy applications and over a clinically relevant 420mm field of view (FOV). As expected and towards the edges of the field of view (FOV), distortion increased with increasing FOV. For all assessed sequences, the vendor GDC was able to reduce the mean distortion to below 1mm over a field of view of 5, 10, 15 and 20cm radius respectively. CONCLUSION: Results issued from the application of the developed phantoms and algorithms demonstrate a high level of precision. The results indicate that this platform represents an important, robust and objective tool to perform routine quality assurance of MR-guided therapeutic applications, where spatial accuracy is paramount.

A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapy.

PURPOSE: Organ motion is a contributory factor to the variation in location of the prostate and organs at risk during a course of fractionated prostate radiation therapy (RT). A prospective randomized controlled trial was designed with the primary endpoint to provide evidence-based bladder-filling instructions to achieve a consistent bladder volume (BV) and thus reduce the bladder-related organ motion. The secondary endpoints were to assess the incidence of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity for patients and patients' satisfaction with the bladder-filling instructions. METHODS AND MATERIALS: One hundred ten patients were randomly assigned to 1 of 2 bladder-filling protocols; 540 mL (3 cups) of water or 1080 mL (6 cups) of water, in a single institution trial. A portable ultrasound device, BladderScan BVI 6400 (Verathon Inc, Bothell, WA), measured BVs at treatment planning computed tomography (TPCT) scan and 3 times per week during RT. Maximum bladder dose and BV receiving ≥ 50, 60, and 70 Gy were recorded. Acute and late GU and GI toxicity were evaluated, as were patients' comfort, perception of urinary symptoms, and quality of life (QoL). RESULTS: There was significantly less BV variation in the 540 mL arm when compared with 1080 mL (median: 76 mL vs 105 mL, P = .003). Larger BVs on initial TPCT correlated with larger BV variations during RT (P < .0005). There were no statistically significant associations between arm and GU/GI toxicity, dose median comfort scores, or median QoL scores. CONCLUSIONS: The 540 mL bladder-filling arm resulted in reproducible BVs throughout a course of RT, without any deterioration in QoL or increase in toxicities for prostate patients.